UGC Approved Journal no 63975

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 9 | Issue 1 | January 2022

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 8 Issue 7
July-2021
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2107519


Registration ID:
311553

Page Number

e125-e139

Share This Article


Jetir RMS

Title

Cancer cell line for mechanisms of clinical anticancer drug resistance

Abstract

Anticancer medications opposition is an unpredictable interaction that emerges from modifying in the medication targets. Advances in the DNA microarray, proteomics innovation and the improvement of designated treatments give the new techniques to beat the medication obstruction. Albeit a plan of the new chemotherapy specialists is developing rapidly, compelling chemotherapy specialist has not been found against the high level phase of malignancy. The cancer cell opposition against the anticancer specialists can be because of numerous elements like the person's hereditary contrasts, particularly in tumoral physical cells. Cancer drug resistance is obtained, the medication obstruction can be happened by various instruments, including multi-drug obstruction, cell passing repressing, adjusting in the medication digestion, epigenetic and drug targets, upgrading DNA repair and gene amplification. We illustrated the instruments of cancer drug obstruction and the therapy failure by normal chemotherapy specialists in the diverse sort of tumors. Chemotherapy is one of the pillars of clinical cancer treatment. In the cancer research, cancer biological qualities is refreshing each day. Cancer causes the uncontrolled development of strange cells and dynamic modifying in the genome (which cause cancerous features in normal cells).

Key Words

Cancer, Chemotherapy, Drug resistance, Multidrug resistance protein, Cell line, Chemo resistance, Mechanisms, Clinical use.

Cite This Article

"Cancer cell line for mechanisms of clinical anticancer drug resistance", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.8, Issue 7, page no.e125-e139, July-2021, Available :http://www.jetir.org/papers/JETIR2107519.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Cancer cell line for mechanisms of clinical anticancer drug resistance", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.8, Issue 7, page no. ppe125-e139, July-2021, Available at : http://www.jetir.org/papers/JETIR2107519.pdf

Publication Details

Published Paper ID: JETIR2107519
Registration ID: 311553
Published In: Volume 8 | Issue 7 | Year July-2021
DOI (Digital Object Identifier):
Page No: e125-e139
Country: Surat, Gujarat, India .
Area: Medical Science
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000165

Print This Page

Current Call For Paper

Jetir RMS